Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 2,495 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. The company develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Based on 7 analysts giving stock ratings to BTTAY, updated on Mar 01, 2025
Sell
Strong buy
0
Buy
0
Hold
3
Sell
3
Strong sell
1
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for BTTAY. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: BTTAY is a Sell candidate.
BTTAY stock price ended at $24.23 on Thursday, after rising 5.58%
On the latest trading day Apr 03, 2025, the stock price of BTTAY rose by 5.58%, climbing from $23.10 to $24.23. During the session, the stock saw a volatility of 4.89%, with prices oscillating between a daily low of $23.10 and a high of $24.23. Notably, trading volume dropped by 101 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 201 shares were traded, equating to a market value of approximately $958.8M.
BTTAY Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
BTTAY currently exhibits 0 buy signals and 0 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of 6.27% during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for BTTAY
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for BTTAY. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to BTTAY?
According to technical analysis, Biotest Aktiengesellschaft has an aggregate signal of Neutral. Biotest Aktiengesellschaft has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What is the RSI for Biotest Aktiengesellschaft?
The RSI for Biotest Aktiengesellschaft is currently NaN, indicating a neutral condition
What is Biotest Aktiengesellschaft price for the next 12 months?
Biotest Aktiengesellschaft BTTAY price for the next 12 months is estimated at $0.
How high is Biotest Aktiengesellschaft expected to go?
According to wall street analysts, Biotest Aktiengesellschaft is expected to reach a high forecast of $0.